Detalles de la búsqueda
1.
Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey.
Oncology
; 93(1): 11-17, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28423384
2.
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients.
Front Oncol
; 11: 714551, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778031
3.
Prognostic factors of survival in head and neck cancer patients treated with surgery and postoperative radiation therapy.
Acta Otolaryngol
; 128(6): 706-12, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18568509
4.
Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer.
Oncotarget
; 9(101): 37581-37588, 2018 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30680071
5.
Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases.
Head Neck
; 27(9): 801-8, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16086415
Resultados
1 -
5
de 5
1
Próxima >
>>